Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of PENAO in combination with mTOR inhibitor

Trial Profile

Phase II trial of PENAO in combination with mTOR inhibitor

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PENAO (Primary) ; MTOR protein inhibitors
  • Indications Cancer; Solid tumours
  • Focus Therapeutic Use

Most Recent Events

  • 16 Sep 2019 New trial record
  • 21 Aug 2018 According to a Beroni Group media release, Beroni has collaboration with a medical group in Japan with extensive hospital and clinical trial facilities. Conducting part of the clinical trials in Japan will strengthen Beroni's application for Japan PMDA's approval of the PENAO drug.
  • 21 Aug 2018 According to a Beroni Group media release, Once the trial has commenced the project team will monitor the progress of these trial sites and more trial sites will be added if necessary to accelerate progress of the clinical trial, particularly in jurisdictions with suitable drug regulation, unmet market need and strong existing collaboration

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top